{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:06:49Z","timestamp":1784311609062,"version":"3.55.0"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07717-x","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T11:34:30Z","timestamp":1769254470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The silent epidemic within the pandemic: pathophysiology and prediction of post-COVID-19 diabetes"],"prefix":"10.1186","volume":"24","author":[{"given":"Hongjuan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4392-0889","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"7717_CR1","doi-asserted-by":"publisher","unstructured":"Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit. 26:e928996. https:\/\/doi.org\/10.12659\/MSM.928996. https:\/\/pubmed.ncbi.nlm.nih.gov\/33177481\/. Published 2020 Nov 1.","DOI":"10.12659\/MSM.928996"},{"key":"7717_CR2","doi-asserted-by":"publisher","unstructured":"Teixeira JP, Barone S, Zahedi K, Soleimani M. Kidney injury in COVID-19: epidemiology, molecular mechanisms and potential therapeutic targets. Int J Mol Sci. 2022;23(4). https:\/\/doi.org\/10.3390\/ijms23042242. https:\/\/pubmed.ncbi.nlm.nih.gov\/35216358\/. Published 2022 Feb 17.","DOI":"10.3390\/ijms23042242"},{"issue":"2","key":"7717_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/HCO.0000000000000832","volume":"36","author":"J Liu","year":"2021","unstructured":"Liu J, Deswal A, Khalid U. COVID-19 myocarditis and long-term heart failure sequelae. Curr Opin Cardiol. 2021;36(2):234\u201340. https:\/\/doi.org\/10.1097\/HCO.0000000000000832. https:\/\/pubmed.ncbi.nlm.nih.gov\/33394709\/.","journal-title":"Curr Opin Cardiol"},{"issue":"11","key":"7717_CR4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3357\/AMHP.5928.2021","volume":"92","author":"SY Ko","year":"2021","unstructured":"Ko SY, Nguyen NK, Lee CL, Lee LA, Nguyen KUT, Lee EC. Aeromedical implications of long-term COVID-19 sequelae. Aerosp Med Hum Perform. 2021;92(11):898\u2013907. https:\/\/doi.org\/10.3357\/AMHP.5928.2021. https:\/\/pubmed.ncbi.nlm.nih.gov\/34819216\/.","journal-title":"Aerosp Med Hum Perform"},{"issue":"10453","key":"7717_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","volume":"404","author":"T Greenhalgh","year":"2024","unstructured":"Greenhalgh T, Sivan M, Perlowski A, Nikolich J\u017d. Long COVID: a clinical update. Lancet. 2024;404(10453):707\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(24)01136-X. https:\/\/pubmed.ncbi.nlm.nih.gov\/39096925\/.","journal-title":"Lancet"},{"issue":"11","key":"7717_CR6","doi-asserted-by":"publisher","first-page":"e1164","DOI":"10.1210\/clinem\/dgad284","volume":"108","author":"SH Kim","year":"2023","unstructured":"Kim SH, Arora I, Hsia DS, et al. New-onset diabetes after COVID-19. J Clin Endocrinol Metab. 2023;108(11):e1164\u201374. https:\/\/doi.org\/10.1210\/clinem\/dgad284. https:\/\/pubmed.ncbi.nlm.nih.gov\/37207448\/.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"7717_CR7","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.2337\/dc21-1318","volume":"44","author":"K Khunti","year":"2021","unstructured":"Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021;44(12):2645\u201355. https:\/\/doi.org\/10.2337\/dc21-1318. https:\/\/pubmed.ncbi.nlm.nih.gov\/34625431\/.","journal-title":"Diabetes Care"},{"issue":"1","key":"7717_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.37796\/2211-8039.1389","volume":"13","author":"DM Wihandani","year":"2023","unstructured":"Wihandani DM, Purwanta MLA, Mulyani WRW, Putra IWAS, Supadmanaba IGP. New-onset diabetes in COVID-19: the molecular pathogenesis. Biomed (Taipei). 2023;13(1):3\u201312. Published 2023 None. doi: https:\/\/doi.org\/10.37796\/2211-8039.1389. https:\/\/pubmed.ncbi.nlm.nih.gov\/37168726\/.","journal-title":"Biomed (Taipei)"},{"issue":"3","key":"7717_CR9","first-page":"177","volume":"121","author":"A Ansar","year":"2022","unstructured":"Ansar A, Livett T, Beaton W, Carrel AL, Bekx MT. Sharp rise in new-onset pediatric diabetes during the COVID-19 pandemic. WMJ. 2022;121(3):177\u201380. https:\/\/pubmed.ncbi.nlm.nih.gov\/36301642\/.","journal-title":"WMJ"},{"key":"7717_CR10","doi-asserted-by":"publisher","unstructured":"Lu JY, Wilson J, Hou W, et al. Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza. EBioMedicine. 90:104487. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104487. https:\/\/pubmed.ncbi.nlm.nih.gov\/36857969\/.","DOI":"10.1016\/j.ebiom.2023.104487"},{"issue":"2","key":"7717_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/archdischild-2020-321220","volume":"107","author":"H Salmi","year":"2022","unstructured":"Salmi H, Heinonen S, H\u00e4stbacka J, et al. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic. Arch Dis Child. 2022;107(2):180\u201385. https:\/\/doi.org\/10.1136\/archdischild-2020-321220. https:\/\/pubmed.ncbi.nlm.nih.gov\/34045208\/.","journal-title":"Arch Dis Child"},{"issue":"1","key":"7717_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s13410-022-01119-7","volume":"43","author":"T Sathish","year":"2023","unstructured":"Sathish T, Anton MC. Persistence of new-onset diabetes in the post-acute phase of COVID-19. Int J Diabetes Dev Ctries. 2023;43(1):118\u201319. https:\/\/doi.org\/10.1007\/s13410-022-01119-7. https:\/\/pubmed.ncbi.nlm.nih.gov\/35892064\/.","journal-title":"Int J Diabetes Dev Ctries"},{"key":"7717_CR13","doi-asserted-by":"publisher","unstructured":"Cocking E, Daher J, Alabbood M. New-onset diabetes mellitus post COVID-19 infection: a systematic review and meta-analysis. Diabetes Res Clin Pract. 227:112417. https:\/\/doi.org\/10.1016\/j.diabres.2025.112417. https:\/\/pubmed.ncbi.nlm.nih.gov\/40803509\/.","DOI":"10.1016\/j.diabres.2025.112417"},{"issue":"5","key":"7717_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5501\/wjv.v10.i5.275","volume":"10","author":"DB Shrestha","year":"2021","unstructured":"Shrestha DB, Budhathoki P, Raut S, et al. New-onset diabetes in COVID-19 and clinical outcomes: a systematic review and meta-analysis. World J Virol. 2021;10(5):275\u201387. https:\/\/doi.org\/10.5501\/wjv.v10.i5.275. https:\/\/pubmed.ncbi.nlm.nih.gov\/34631477\/.","journal-title":"World J Virol"},{"key":"7717_CR15","doi-asserted-by":"publisher","unstructured":"Li J, Li Y, Wang Z, Liu N, He L, Zhang H. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front Public Health. 11:1170156. Published 2023 None. doi: https:\/\/doi.org\/10.3389\/fpubh.2023.1170156. https:\/\/pubmed.ncbi.nlm.nih.gov\/37304092\/.","DOI":"10.3389\/fpubh.2023.1170156"},{"issue":"2","key":"7717_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jaci.2020.05.033","volume":"146","author":"K Hosoki","year":"2020","unstructured":"Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist\u2019s perspective. J Allergy Clin Immunol. 2020;146(2):285\u201399. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.033. https:\/\/pubmed.ncbi.nlm.nih.gov\/32624257\/.","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"7717_CR17","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.26355\/eurrev_202211_30169","volume":"26","author":"FA Alomar","year":"2022","unstructured":"Alomar FA. Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes. Eur Rev Med Pharmacol Sci. 2022;26(21):8152\u201371. https:\/\/doi.org\/10.26355\/eurrev_202211_30169. https:\/\/pubmed.ncbi.nlm.nih.gov\/36394765\/.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"7717_CR18","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.4103\/jfmpc.jfmpc_316_22","volume":"11","author":"BY Keerthi","year":"2022","unstructured":"Keerthi BY, Sushmita G, Khan EA, et al. New onset diabetes mellitus in post-COVID-19 patients. J Fam Med Prim Care. 2022;11(10):5961\u201368. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_316_22. https:\/\/pubmed.ncbi.nlm.nih.gov\/36618178\/.","journal-title":"J Fam Med Prim Care"},{"issue":"2","key":"7717_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/17446651.2023.2176300","volume":"18","author":"J Faruqi","year":"2023","unstructured":"Faruqi J, Balasubramanyam A. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic. Expert Rev Endocrinol Metab. 2023;18(2):167\u201379. https:\/\/doi.org\/10.1080\/17446651.2023.2176300. https:\/\/pubmed.ncbi.nlm.nih.gov\/36797835\/.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"7717_CR20","doi-asserted-by":"publisher","unstructured":"Izzo R, Pacella D, Trimarco V, et al. Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study. EClinicalMedicine. 66:102345. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102345. https:\/\/pubmed.ncbi.nlm.nih.gov\/38143804\/. Published 2023 Dec.","DOI":"10.1016\/j.eclinm.2023.102345"},{"issue":"6","key":"7717_CR21","doi-asserted-by":"publisher","first-page":"e2321281","DOI":"10.1001\/jamanetworkopen.2023.21281","volume":"6","author":"D D\u2019Souza","year":"2023","unstructured":"D\u2019Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R. Incidence of diabetes in children and adolescents during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(6):e2321281. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.21281. https:\/\/pubmed.ncbi.nlm.nih.gov\/37389869\/. Published 2023 Jun 1.","journal-title":"JAMA Netw Open"},{"key":"7717_CR22","doi-asserted-by":"publisher","unstructured":"Camacho Moll ME, Mata Tijerina VL, Silva Ram\u00edrez, et al. Sex, age, and comorbidities are associated with SARS-CoV-2 infection, COVID-19 severity, and fatal outcome in a Mexican population: a retrospective multi-hospital study. J Clin Med. 2023;12(7). Published https:\/\/doi.org\/10.3390\/jcm12072676. https:\/\/pubmed.ncbi.nlm.nih.gov\/37048758\/. 2023 Apr 3.","DOI":"10.3390\/jcm12072676"},{"key":"7717_CR23","doi-asserted-by":"publisher","unstructured":"Kirillov Y, Timofeev S, Avdalyan A, Nikolenko VN, Gridin L, Sinelnikov MY. Analysis of risk factors in COVID-19 adult mortality in Russia. J Prim Care Community Health. 12:21501327211008050. https:\/\/doi.org\/10.1177\/21501327211008050. https:\/\/pubmed.ncbi.nlm.nih.gov\/33829916\/.","DOI":"10.1177\/21501327211008050"},{"issue":"6","key":"7717_CR24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.pcd.2021.08.014","volume":"15","author":"Y Yin","year":"2021","unstructured":"Yin Y, Rohli KE, Shen P, et al. The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with type 2 diabetes: a systematic review. Prim Care Diabetes. 2021;15(6):899\u2013909. https:\/\/doi.org\/10.1016\/j.pcd.2021.08.014. https:\/\/pubmed.ncbi.nlm.nih.gov\/34600859\/.","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"7717_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmet.2021.01.016","volume":"33","author":"DJ Drucker","year":"2021","unstructured":"Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab. 2021;33(3):479\u201398. https:\/\/doi.org\/10.1016\/j.cmet.2021.01.016. https:\/\/pubmed.ncbi.nlm.nih.gov\/33529600\/.","journal-title":"Cell Metab"},{"issue":"3","key":"7717_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s13410-021-00930-y","volume":"41","author":"L Moftakhar","year":"2021","unstructured":"Moftakhar L, Moftakhar P, Piraee E, Ghaem H, Valipour A, Azarbakhsh H. Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients. Int J Diabetes Dev Ctries. 2021;41(3):383\u201388. https:\/\/doi.org\/10.1007\/s13410-021-00930-y. https:\/\/pubmed.ncbi.nlm.nih.gov\/33584062\/.","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"1","key":"7717_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.dsx.2020.12.037","volume":"15","author":"A Saha","year":"2021","unstructured":"Saha A, Ahsan MM, Quader MT, et al. Clinical characteristics and outcomes of COVID-19 infected diabetic patients admitted in ICUs of the southern region of Bangladesh. Diabetes Metab Syndr. 2021, Jan-Feb;15(1):229\u201335. https:\/\/doi.org\/10.1016\/j.dsx.2020.12.037. https:\/\/pubmed.ncbi.nlm.nih.gov\/33445071\/.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"7717_CR28","doi-asserted-by":"publisher","first-page":"e211020187087","DOI":"10.2174\/1573399816666201021154839","volume":"17","author":"MA Al Dawish","year":"2021","unstructured":"Al Dawish MA, Robert AA. COVID-19 in people with diabetes: epidemiological perspectives and public health actions in the middle East and North Africa (MENA) region. Curr Diabetes Rev. 2021;17(5):e211020187087. https:\/\/doi.org\/10.2174\/1573399816666201021154839. https:\/\/pubmed.ncbi.nlm.nih.gov\/33087031\/.","journal-title":"Curr Diabetes Rev"},{"issue":"6","key":"7717_CR29","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jaci.2020.09.017","volume":"146","author":"C Skevaki","year":"2020","unstructured":"Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020;146(6):1295\u2013301. https:\/\/doi.org\/10.1016\/j.jaci.2020.09.017. https:\/\/pubmed.ncbi.nlm.nih.gov\/33002516\/.","journal-title":"J Allergy Clin Immunol"},{"key":"7717_CR30","doi-asserted-by":"publisher","unstructured":"Gruber N, Brand L, Barhod E, et al. The effect of COVID-19 on type 1 diabetes occurrence among children and adolescents: a multicenter prospective Observational cohort study in Israel. Pediatr Diabetes. 2023;6659719. Published 2023 None. doi: https:\/\/doi.org\/10.1155\/2023\/6659719. https:\/\/pubmed.ncbi.nlm.nih.gov\/40303246\/.","DOI":"10.1155\/2023\/6659719"},{"issue":"12","key":"7717_CR31","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.2337\/dbi21-0029","volume":"70","author":"AA Metwally","year":"2021","unstructured":"Metwally AA, Mehta P, Johnson BS, Nagarjuna A, Snyder MP. COVID-19-Induced new-onset diabetes: trends and technologies. Diabetes. 2021;70(12):2733\u201344. https:\/\/doi.org\/10.2337\/dbi21-0029. https:\/\/pubmed.ncbi.nlm.nih.gov\/34686519\/.","journal-title":"Diabetes"},{"issue":"4","key":"7717_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/pediatric14040060","volume":"14","author":"E Hurissi","year":"2022","unstructured":"Hurissi E, Alameer M, Ageeli F, et al. The association between SARS-CoV-2 infection and diabetic Ketoacidosis in patients with new-onset diabetes: a retrospective study from a diabetic center in Saudi Arabia. Pediatr Rep. 2022;14(4):519\u201327. https:\/\/doi.org\/10.3390\/pediatric14040060. https:\/\/pubmed.ncbi.nlm.nih.gov\/36548203\/. Published 2022 Nov 29.","journal-title":"Pediatr Rep"},{"issue":"7","key":"7717_CR33","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/pedi.13396","volume":"23","author":"NT Agathis","year":"2022","unstructured":"Agathis NT, Womack LS, Webber BJ, et al. Children, adolescents, and young adults hospitalized with COVID-19 and diabetes in summer 2021. Pediatr Diabetes. 2022;23(7):961\u201367. https:\/\/doi.org\/10.1111\/pedi.13396. https:\/\/pubmed.ncbi.nlm.nih.gov\/35876454\/.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"7717_CR34","doi-asserted-by":"publisher","first-page":"2203782","DOI":"10.1080\/22221751.2023.2203782","volume":"12","author":"Q Huang","year":"2023","unstructured":"Huang Q, An R, Wang H, et al. Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice. Emerg Microbes Infect. 2023;12(1):2203782. https:\/\/doi.org\/10.1080\/22221751.2023.2203782. https:\/\/pubmed.ncbi.nlm.nih.gov\/37060137\/.","journal-title":"Emerg Microbes Infect"},{"key":"7717_CR35","doi-asserted-by":"publisher","unstructured":"Johnson R, Ardunay J, Hammond H, et al. Diet induced obesity and diabetes enhance mortality and reduces vaccine efficacy for SARS-CoV-2. bioRxiv. https:\/\/doi.org\/10.1101\/2022.10.15.512291. https:\/\/pubmed.ncbi.nlm.nih.gov\/36299426\/. Published 2023 May 5.","DOI":"10.1101\/2022.10.15.512291"},{"issue":"8","key":"7717_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11892-023-01515-1","volume":"23","author":"R Wong","year":"2023","unstructured":"Wong R, Lam E, Bramante CT, et al. Does COVID-19 infection increase the risk of diabetes? Curr Evidence. Curr Diab Rep. 2023;23(8):207\u201316. https:\/\/doi.org\/10.1007\/s11892-023-01515-1. https:\/\/pubmed.ncbi.nlm.nih.gov\/37284921\/.","journal-title":"Curr Evidence. Curr Diab Rep"},{"issue":"4","key":"7717_CR37","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2337\/dc22-1943","volume":"46","author":"R Li","year":"2023","unstructured":"Li R, Shen M, Yang Q, et al. Global diabetes prevalence in COVID-19 patients and contribution to COVID-19- related severity and mortality: a systematic review and meta-analysis. Diabetes Care. 2023;46(4):890\u201397. https:\/\/doi.org\/10.2337\/dc22-1943. https:\/\/pubmed.ncbi.nlm.nih.gov\/36826982\/.","journal-title":"Diabetes Care"},{"issue":"1","key":"7717_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.dsx.2021.01.005","volume":"15","author":"K Gaur","year":"2021","unstructured":"Gaur K, Khedar RS, Mangal K, Sharma AK, Dhamija RK, Gupta R. Macrolevel association of COVID-19 with non-communicable disease risk factors in India. Diabetes Metab Syndr. 2021, Jan-Feb;15(1):343\u201350. https:\/\/doi.org\/10.1016\/j.dsx.2021.01.005. https:\/\/pubmed.ncbi.nlm.nih.gov\/33503583\/.","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"7717_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cmet.2021.02.006","volume":"33","author":"WT Cefalu","year":"2021","unstructured":"Cefalu WT, Rodgers GP. COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research priorities. Cell Metab. 2021;33(3):473\u201378. https:\/\/doi.org\/10.1016\/j.cmet.2021.02.006. https:\/\/pubmed.ncbi.nlm.nih.gov\/33581046\/.","journal-title":"Cell Metab"},{"key":"7717_CR40","doi-asserted-by":"publisher","unstructured":"Jean-Louis G, Turner AD, Jin P, et al. Increased metabolic burden among blacks: a Putative mechanism for disparate COVID-19 outcomes. Diabetes Metab Syndr Obes. 13:3471\u201379. Published 2020 None. doi: https:\/\/doi.org\/10.2147\/DMSO.S267952. https:\/\/pubmed.ncbi.nlm.nih.gov\/33061507\/.","DOI":"10.2147\/DMSO.S267952"},{"key":"7717_CR41","doi-asserted-by":"publisher","unstructured":"Summan A, Nandi A, Wahl B, et al. Estimates of hospitalisations and deaths in patients with COVID-19 associated with undiagnosed diabetes during the first phase of the pandemic in eight low-income and middle-income countries: a modelling study. EClinicalMedicine. 70:102492. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102492. https:\/\/pubmed.ncbi.nlm.nih.gov\/38481788\/. Published 2024 Apr.","DOI":"10.1016\/j.eclinm.2024.102492"},{"issue":"5","key":"7717_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","volume":"10","author":"Y Xie","year":"2022","unstructured":"Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311\u201321. https:\/\/doi.org\/10.1016\/S2213-8587(22)00044-4. https:\/\/pubmed.ncbi.nlm.nih.gov\/35325624\/.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10440","key":"7717_CR43","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021. A systematic analysis for the global burden of disease study 2021","year":"2024","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021. A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/38642570\/.","journal-title":"Lancet"},{"issue":"1","key":"7717_CR44","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12889-022-13169-x","volume":"22","author":"MR Angeles","year":"2022","unstructured":"Angeles MR, Wanni Arachchige Dona S, Nguyen HD, Le LK, Hensher M. Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan. BMC Public Health. 2022;22(1):757. https:\/\/doi.org\/10.1186\/s12889-022-13169-x. https:\/\/pubmed.ncbi.nlm.nih.gov\/35421963\/. Published 2022 Apr 14.","journal-title":"BMC Public Health"},{"issue":"4","key":"7717_CR45","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2468-2667(25)00045-3","volume":"10","author":"M Naghavi","year":"2025","unstructured":"Naghavi M. State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the global burden of disease study 2021. Lancet Public Health. 2025;10(4):e309\u201320. https:\/\/doi.org\/10.1016\/S2468-2667(25)00045-3. https:\/\/pubmed.ncbi.nlm.nih.gov\/40175012\/.","journal-title":"Lancet Public Health"},{"issue":"1","key":"7717_CR46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12939-021-01547-7","volume":"20","author":"GMA Wyper","year":"2021","unstructured":"Wyper GMA, Fletcher E, Grant I, et al. Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland. Int J Equity Health. 2021;20(1):214. https:\/\/doi.org\/10.1186\/s12939-021-01547-7. https:\/\/pubmed.ncbi.nlm.nih.gov\/34565406\/. Published 2021 Sep 26.","journal-title":"Int J Equity Health"},{"key":"7717_CR47","doi-asserted-by":"publisher","unstructured":"Chen X, Lin H, Wu Y, Wang M, Lin S, Huang J. The impact of the COVID-19 pandemic on the global burden of type 2 diabetes: a study based on GBD, 2021 data. Front Endocrinol (Lausanne). 16:1600333. Published 2025 None. doi: https:\/\/doi.org\/10.3389\/fendo.2025.1600333. https:\/\/pubmed.ncbi.nlm.nih.gov\/41169462\/.","DOI":"10.3389\/fendo.2025.1600333"},{"issue":"6","key":"7717_CR48","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2020.11.006","volume":"32","author":"KC Coate","year":"2020","unstructured":"Coate KC, Cha J, Shrestha S, et al. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not Enriched in \u03b2 cells. Cell Metab. 2020;32(6):1028\u201340.e4. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.006. https:\/\/pubmed.ncbi.nlm.nih.gov\/33207245\/.","journal-title":"Cell Metab"},{"key":"7717_CR49","doi-asserted-by":"publisher","unstructured":"Coate KC, Cha J, Shrestha S, et al. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the pancreas but are not Enriched in islet endocrine cells. bioRxiv. Published. 2020, Oct, 20. https:\/\/doi.org\/10.1101\/2020.08.31.275719. https:\/\/pubmed.ncbi.nlm.nih.gov\/33106804\/.","DOI":"10.1101\/2020.08.31.275719"},{"key":"7717_CR50","doi-asserted-by":"publisher","unstructured":"Fignani D, Licata G, Brusco N, et al. SARS-CoV-2 receptor angiotensin I-Converting enzyme type 2 (ACE2) is Expressed in human pancreatic \u03b2-cells and in the human pancreas Microvasculature. Front Endocrinol (Lausanne). 11:596898. Published 2020 None. doi: https:\/\/doi.org\/10.3389\/fendo.2020.596898. https:\/\/pubmed.ncbi.nlm.nih.gov\/33281748\/.","DOI":"10.3389\/fendo.2020.596898"},{"issue":"3","key":"7717_CR51","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2337\/db24-0816","volume":"74","author":"C Andrade Barboza","year":"2025","unstructured":"Andrade Barboza C, Gon\u00e7alves, Pereira E, et al. SARS-CoV-2 Spike S1 subunit triggers pericyte and microvascular dysfunction in human pancreatic islets. Diabetes. 2025;74(3):355\u201367. https:\/\/doi.org\/10.2337\/db24-0816. https:\/\/pubmed.ncbi.nlm.nih.gov\/39715591\/.","journal-title":"Diabetes"},{"issue":"7","key":"7717_CR52","doi-asserted-by":"publisher","first-page":"104594","DOI":"10.1016\/j.isci.2022.104594","volume":"25","author":"WJ Szlachcic","year":"2022","unstructured":"Szlachcic WJ, Dabrowska A, Milewska A, et al. SARS-CoV-2 infects an in vitro model of the human developing pancreas through endocytosis. iScience. 2022;25(7):104594. https:\/\/doi.org\/10.1016\/j.isci.2022.104594. https:\/\/pubmed.ncbi.nlm.nih.gov\/35756892\/.","journal-title":"iScience"},{"issue":"8","key":"7717_CR53","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","volume":"33","author":"CT Wu","year":"2021","unstructured":"Wu CT, Lidsky PV, Xiao Y, et al. SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment. Cell Metab. 2021;33(8):1565\u201376.e5. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.013. https:\/\/pubmed.ncbi.nlm.nih.gov\/34081912\/.","journal-title":"Cell Metab"},{"issue":"1","key":"7717_CR54","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1038\/s41467-021-23886-3","volume":"12","author":"C Steenblock","year":"2021","unstructured":"Steenblock C, Richter S, Berger I, et al. Viral infiltration of pancreatic islets in patients with COVID-19. Nat Commun. 2021;12(1):3534. https:\/\/doi.org\/10.1038\/s41467-021-23886-3. https:\/\/pubmed.ncbi.nlm.nih.gov\/34112801\/. Published 2021 Jun 10.","journal-title":"Nat Commun"},{"issue":"1","key":"7717_CR55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41392-024-01790-8","volume":"9","author":"H Meng","year":"2024","unstructured":"Meng H, Liao Z, Ji Y, et al. FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection. Signal Transduct Target Ther. 2024;9(1):104. Published https:\/\/doi.org\/10.1038\/s41392-024-01790-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/38654010\/. 2024 Apr 23.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"7717_CR56","doi-asserted-by":"publisher","first-page":"110508","DOI":"10.1016\/j.celrep.2022.110508","volume":"38","author":"van der Heide V","year":"2022","unstructured":"van der Heide V, Jangra S, Cohen P, et al. Limited extent and consequences of pancreatic SARS-CoV-2 infection. Cell Rep. 2022;38(11):110508. https:\/\/doi.org\/10.1016\/j.celrep.2022.110508. https:\/\/pubmed.ncbi.nlm.nih.gov\/35247306\/.","journal-title":"Cell Rep"},{"issue":"2","key":"7717_CR57","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1530\/JME-21-0282","volume":"69","author":"R Rangu","year":"2022","unstructured":"Rangu R, Wander PL, Barrow BM, Zraika S. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2. J Mol Endocrinol. 2022;69(2):R63\u201379. https:\/\/doi.org\/10.1530\/JME-21-0282. https:\/\/pubmed.ncbi.nlm.nih.gov\/35521990\/. Published 2022 Jun 17.","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"7717_CR58","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/1753-0407.13085","volume":"12","author":"A Rajpal","year":"2020","unstructured":"Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 2020;12(12):895\u2013908. https:\/\/doi.org\/10.1111\/1753-0407.13085. https:\/\/pubmed.ncbi.nlm.nih.gov\/32671936\/.","journal-title":"J Diabetes"},{"issue":"12","key":"7717_CR59","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1089\/omi.2021.0155","volume":"25","author":"H Sasidharakurup","year":"2021","unstructured":"Sasidharakurup H, Kumar G, Nair B, Diwakar S. Mathematical modeling of severe acute respiratory syndrome coronavirus 2 infection network with cytokine storm, oxidative stress, thrombosis, insulin resistance, and nitric oxide pathways. OMICS. 2021;25(12):770\u201381. https:\/\/doi.org\/10.1089\/omi.2021.0155. https:\/\/pubmed.ncbi.nlm.nih.gov\/34807729\/.","journal-title":"OMICS"},{"issue":"7","key":"7717_CR60","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.4239\/wjd.v12.i7.1026","volume":"12","author":"R Viurcos-Sanabria","year":"2021","unstructured":"Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes. 2021;12(7):1026\u201341. https:\/\/doi.org\/10.4239\/wjd.v12.i7.1026. https:\/\/pubmed.ncbi.nlm.nih.gov\/34326952\/.","journal-title":"World J Diabetes"},{"key":"7717_CR61","doi-asserted-by":"publisher","unstructured":"Zuccotti G, Calcaterra V, Mannarino S, et al. Six-month multidisciplinary follow-up in multisystem inflammatory syndrome in children: an Italian single-center experience. Front Pediatr. 10:1080654. Published 2022 None. doi: https:\/\/doi.org\/10.3389\/fped.2022.1080654. https:\/\/pubmed.ncbi.nlm.nih.gov\/36776681\/.","DOI":"10.3389\/fped.2022.1080654"},{"key":"7717_CR62","doi-asserted-by":"publisher","unstructured":"Alipour M, Javeshghani D, Roustazadeh A. Gene expression pattern in severely progressing covid-19 patients is related to diabetes mellitus type 1: a functional annotation analysis. Hum Gene (Amst). 33:201039. https:\/\/doi.org\/10.1016\/j.humgen.2022.201039. https:\/\/pubmed.ncbi.nlm.nih.gov\/37520164\/.","DOI":"10.1016\/j.humgen.2022.201039"},{"issue":"3\u20134","key":"7717_CR63","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/19382014.2021.1909970","volume":"13","author":"S Ibrahim","year":"2021","unstructured":"Ibrahim S, Monaco GSF, Sims EK. Not so sweet and simple: impacts of SARS-CoV-2 on the \u03b2 cell. Islets. 2021;13(3\u20134):66\u201379. https:\/\/doi.org\/10.1080\/19382014.2021.1909970. https:\/\/pubmed.ncbi.nlm.nih.gov\/33970787\/.","journal-title":"Islets"},{"issue":"28","key":"7717_CR64","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.12998\/wjcc.v9.i28.8327","volume":"9","author":"S Sen","year":"2021","unstructured":"Sen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: understanding the association in light of current evidence. World J Clin Cases. 2021;9(28):8327\u201339. https:\/\/doi.org\/10.12998\/wjcc.v9.i28.8327. https:\/\/pubmed.ncbi.nlm.nih.gov\/34754842\/.","journal-title":"World J Clin Cases"},{"key":"7717_CR65","doi-asserted-by":"publisher","unstructured":"Prakash S, Choudhury P, Bisht S. Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk. Front Pharmacol. 16:1683159. Published 2025 None. doi: https:\/\/doi.org\/10.3389\/fphar.2025.1683159. https:\/\/pubmed.ncbi.nlm.nih.gov\/41158128\/.","DOI":"10.3389\/fphar.2025.1683159"},{"key":"7717_CR66","doi-asserted-by":"publisher","unstructured":"Santos E Silva JC, Vasconcelos AP, Noma IHY, et al. Gene signatures of autopsy lungs from obese patients with COVID-19. Clin Nutr ESPEN. 44:475\u201378. https:\/\/doi.org\/10.1016\/j.clnesp.2021.05.004. https:\/\/pubmed.ncbi.nlm.nih.gov\/34330510\/.","DOI":"10.1016\/j.clnesp.2021.05.004"},{"key":"7717_CR67","doi-asserted-by":"publisher","unstructured":"Zangiabadian M, Nejadghaderi SA, Zahmatkesh MM, Hajikhani B, Mirsaeidi M, Nasiri MJ. The efficacy and potential mechanisms of metformin in the treatment of COVID-19 in the diabetics: a systematic review. Front Endocrinol (Lausanne). 12:645194. Published 2021 None. doi: https:\/\/doi.org\/10.3389\/fendo.2021.645194. https:\/\/pubmed.ncbi.nlm.nih.gov\/33815295\/.","DOI":"10.3389\/fendo.2021.645194"},{"issue":"4","key":"7717_CR68","doi-asserted-by":"publisher","first-page":"167726","DOI":"10.1016\/j.bbadis.2025.167726","volume":"1871","author":"Q Meng","year":"2025","unstructured":"Meng Q, Jacob I, Wang C, et al. Pathogenesis and therapeutic effect of sitagliptin in experimental diabetic model of COVID-19. Biochim Biophys Acta Mol Basis Dis. 2025;1871(4):167726. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167726. https:\/\/pubmed.ncbi.nlm.nih.gov\/39971257\/.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7717_CR69","doi-asserted-by":"publisher","unstructured":"Mbambara S, Modipane N, Serite T, Sathekge M, Kgatle M. The role of aryl hydrocarbon receptor signalling in COVID-19 pathology and its therapeutic potential. Front Mol Med. 5:1599785. Published 2025 None. doi: https:\/\/doi.org\/10.3389\/fmmed.2025.1599785. https:\/\/pubmed.ncbi.nlm.nih.gov\/40949107\/.","DOI":"10.3389\/fmmed.2025.1599785"},{"issue":"9","key":"7717_CR70","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","volume":"18","author":"JX Li","year":"2022","unstructured":"Li JX, Cummins CL. Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions. Nat Rev Endocrinol. 2022;18(9):540\u201357. https:\/\/doi.org\/10.1038\/s41574-022-00683-6. https:\/\/pubmed.ncbi.nlm.nih.gov\/35585199\/.","journal-title":"Nat Rev Endocrinol"},{"key":"7717_CR71","doi-asserted-by":"publisher","unstructured":"Reiterer M, Rajan M, G\u00f3mez-Banoy N, et al. Hyperglycemia in acute COVID-19 is characterized by adipose tissue dysfunction and insulin resistance. medRxiv. Published. 2021, Mar, 26. https:\/\/doi.org\/10.1101\/2021.03.21.21254072. https:\/\/pubmed.ncbi.nlm.nih.gov\/33791724\/.","DOI":"10.1101\/2021.03.21.21254072"},{"key":"7717_CR72","doi-asserted-by":"publisher","unstructured":"Chen TC, Kuo T, Dandan M, et al. The role of striated muscle Pik3r1 in glucose and protein metabolism following chronic glucocorticoid exposure. J Biol Chem. 296:100395. https:\/\/doi.org\/10.1016\/j.jbc.2021.100395. https:\/\/pubmed.ncbi.nlm.nih.gov\/33567340\/.","DOI":"10.1016\/j.jbc.2021.100395"},{"key":"7717_CR73","doi-asserted-by":"publisher","unstructured":"Bell RMB, Villalobos E, Nixon M, et al. Carbonyl reductase 1 amplifies glucocorticoid action in adipose tissue and impairs glucose tolerance in lean mice. Mol Metab. 48:101225. https:\/\/doi.org\/10.1016\/j.molmet.2021.101225. https:\/\/pubmed.ncbi.nlm.nih.gov\/33785425\/.","DOI":"10.1016\/j.molmet.2021.101225"},{"key":"7717_CR74","doi-asserted-by":"publisher","unstructured":"Villalobos E, Miguelez-Crespo A, Morgan RA, et al. ATP-binding cassette family C member 1 constrains metabolic responses to high-fat diet in male mice. J Endocrinol. 2024;262(2). https:\/\/doi.org\/10.1530\/JOE-24-0024. https:\/\/pubmed.ncbi.nlm.nih.gov\/38829241\/. Published 2024 Aug 1.","DOI":"10.1530\/JOE-24-0024"},{"key":"7717_CR75","doi-asserted-by":"publisher","unstructured":"Sep\u00falveda-Qui\u00f1enao C, Rodriguez JM, D\u00edaz-Castro F, Del Campo A, Bravo-Sagua R, Troncoso R. Glucocorticoid receptor \u03b2 Overexpression has agonist-independent insulin-mimetic effects on HepG2 glucose metabolism. Int J Mol Sci. 2022;23(10). https:\/\/doi.org\/10.3390\/ijms23105582. https:\/\/pubmed.ncbi.nlm.nih.gov\/35628392\/. Published 2022 May 17.","DOI":"10.3390\/ijms23105582"},{"key":"7717_CR76","doi-asserted-by":"publisher","unstructured":"Li S, Zhang S, Rensen PCN, Meijer OC, Kooijman S, Kroon J. Out-of-phase treatment with the synthetic glucocorticoid betamethasone disturbs glucose metabolism in mice. Life Sci. 357:123080. https:\/\/doi.org\/10.1016\/j.lfs.2024.123080. https:\/\/pubmed.ncbi.nlm.nih.gov\/39332486\/.","DOI":"10.1016\/j.lfs.2024.123080"},{"key":"7717_CR77","doi-asserted-by":"publisher","unstructured":"Durumutla HB, Prabakaran AD, Soussi FEA, et al. Glucocorticoid chrono-pharmacology unveils novel targets for the cardiomyocyte-specific GR-KLF15 axis in cardiac glucose metabolism. bioRxiv. https:\/\/doi.org\/10.1101\/2023.12.18.572210. https:\/\/pubmed.ncbi.nlm.nih.gov\/38187555\/. Published 2024 Sep 11.","DOI":"10.1101\/2023.12.18.572210"},{"issue":"6","key":"7717_CR78","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1093\/rheumatology\/keaa724","volume":"60","author":"KM Nowak","year":"2021","unstructured":"Nowak KM, Rdzanek-Pikus M, Romanowska-Pr\u00f3chnicka K, Nowakowska-P\u0142aza A, Papierska L. High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study. Rheumatol (Oxford). 2021;60(6):2842\u201351. https:\/\/doi.org\/10.1093\/rheumatology\/keaa724. https:\/\/pubmed.ncbi.nlm.nih.gov\/33254223\/.","journal-title":"Rheumatol (Oxford)"},{"issue":"4","key":"7717_CR79","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00467-019-04360-1","volume":"35","author":"T Takahashi","year":"2020","unstructured":"Takahashi T, Okamoto T, Sato Y, Hayashi A, Ueda Y, Ariga T. Glucose metabolism disorders in children with refractory nephrotic syndrome. Pediatr Nephrol. 2020;35(4):649\u201357. https:\/\/doi.org\/10.1007\/s00467-019-04360-1. https:\/\/pubmed.ncbi.nlm.nih.gov\/31950245\/.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"7717_CR80","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.dsx.2021.02.034","volume":"15","author":"T Sathish","year":"2021","unstructured":"Sathish T, Chandrika Anton M. Newly diagnosed diabetes in patients with mild to moderate COVID-19. Diabetes Metab Syndr. 2021, Mar-Apr;15(2):569\u201371. https:\/\/doi.org\/10.1016\/j.dsx.2021.02.034. https:\/\/pubmed.ncbi.nlm.nih.gov\/33706188\/.","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"7717_CR81","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.amjms.2022.04.027","volume":"364","author":"D Landis","year":"2022","unstructured":"Landis D, Sutter A, Fernandez F, Nugent K. The effect of metformin on glucose metabolism in patients receiving glucocorticoids. Am J Med Sci. 2022;364(4):379\u201385. https:\/\/doi.org\/10.1016\/j.amjms.2022.04.027. https:\/\/pubmed.ncbi.nlm.nih.gov\/35525318\/.","journal-title":"Am J Med Sci"},{"issue":"1","key":"7717_CR82","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12902-020-00561-0","volume":"20","author":"CK Klarskov","year":"2020","unstructured":"Klarskov CK, Holm Schultz H, Persson F, et al. Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH insulin for sTeroid diAbetes) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment. BMC Endocr Disord. 2020;20(1):86. https:\/\/doi.org\/10.1186\/s12902-020-00561-0. https:\/\/pubmed.ncbi.nlm.nih.gov\/32539810\/. Published 2020 Jun 15.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"7717_CR83","doi-asserted-by":"publisher","first-page":"6","DOI":"10.17691\/stm2020.12.5.01","volume":"12","author":"DV Belikina","year":"2021","unstructured":"Belikina DV, Malysheva ES, Petrov AV, et al. COVID-19 in patients with diabetes: clinical course, metabolic status, inflammation, and coagulation disorder. Sovrem Tekhnologii Med. 2021;12(5):6\u201316. https:\/\/doi.org\/10.17691\/stm2020.12.5.01. https:\/\/pubmed.ncbi.nlm.nih.gov\/34796000\/.","journal-title":"Sovrem Tekhnologii Med"},{"issue":"4","key":"7717_CR84","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s13340-021-00502-9","volume":"12","author":"VP Papadopoulos","year":"2021","unstructured":"Papadopoulos VP, Koutroulos MV, Zikoudi DG, et al. Diabetes-related acute metabolic emergencies in COVID-19 patients: a systematic review and meta-analysis. Diabetol Int. 2021;12(4):445\u201359. https:\/\/doi.org\/10.1007\/s13340-021-00502-9. https:\/\/pubmed.ncbi.nlm.nih.gov\/33777611\/. Published 2021 Oct.","journal-title":"Diabetol Int"},{"issue":"6","key":"7717_CR85","doi-asserted-by":"publisher","first-page":"752","DOI":"10.5005\/jp-journals-10071-24257","volume":"26","author":"S Vadi","year":"2022","unstructured":"Vadi S, Bajpe S, Kulkarni N. Diabetic Ketoacidosis with lower-than-anticipated glucose levels, and recalcitrant metabolic acidosis requiring rescue hemodialysis in a patient of COVID-19 infection. Indian J Crit Care Med. 2022;26(6):752\u201354. https:\/\/doi.org\/10.5005\/jp-journals-10071-24257. https:\/\/pubmed.ncbi.nlm.nih.gov\/35836623\/.","journal-title":"Indian J Crit Care Med"},{"key":"7717_CR86","doi-asserted-by":"publisher","unstructured":"Bharadwaj S, Singh M, Kirtipal N, Kang SG. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered pathogenesis via metabolic reprograming of Glutamine in host cells. Front Mol Biosci. 7:627842. Published 2020 None. doi: https:\/\/doi.org\/10.3389\/fmolb.2020.627842. https:\/\/pubmed.ncbi.nlm.nih.gov\/33585567\/.","DOI":"10.3389\/fmolb.2020.627842"},{"issue":"1","key":"7717_CR87","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-021-00726-w","volume":"6","author":"M Tian","year":"2021","unstructured":"Tian M, Liu W, Li X, et al. HIF-1\u03b1 promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct Target Ther. 2021;6(1):308. https:\/\/doi.org\/10.1038\/s41392-021-00726-w. https:\/\/pubmed.ncbi.nlm.nih.gov\/34408131\/. Published 2021 Aug 18.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"7717_CR88","doi-asserted-by":"publisher","first-page":"e70581","DOI":"10.1111\/jcmm.70581","volume":"29","author":"G Rao","year":"2025","unstructured":"Rao G, Sang X, Zhu X, et al. Pathological glucose levels enhance entry factor expression and hepatic SARS-CoV-2 infection. J Cell Mol Med. 2025;29(11):e70581. https:\/\/doi.org\/10.1111\/jcmm.70581. https:\/\/pubmed.ncbi.nlm.nih.gov\/40442985\/.","journal-title":"J Cell Mol Med"},{"key":"7717_CR89","doi-asserted-by":"publisher","unstructured":"Li Z, Lu Q, Zhang R, et al. Metabolic memory in gestational diabetes enhances SARS-CoV-2 susceptibility in postpartum women: a prospective cohort study integrated with longitudinal metabolomics. Endocr Connect. 2025;14(4). https:\/\/doi.org\/10.1530\/EC-24-0681. https:\/\/pubmed.ncbi.nlm.nih.gov\/40019194\/.","DOI":"10.1530\/EC-24-0681"},{"key":"7717_CR90","doi-asserted-by":"publisher","unstructured":"Lodge S, Lawler NG, Gray N, et al. Integrative plasma metabolic and lipidomic modelling of SARS-CoV-2 infection in relation to clinical severity and early mortality prediction. Int J Mol Sci. 2023;24(14). https:\/\/doi.org\/10.3390\/ijms241411614. https:\/\/pubmed.ncbi.nlm.nih.gov\/37511373\/. Published 2023 Jul 18.","DOI":"10.3390\/ijms241411614"},{"issue":"3","key":"7717_CR91","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40618-021-01693-3","volume":"45","author":"PE Bhavya","year":"2022","unstructured":"Bhavya PE, Mishra R. Deciphering the link between diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas. J Endocrinol Invest. 2022;45(3):537\u201350. https:\/\/doi.org\/10.1007\/s40618-021-01693-3. https:\/\/pubmed.ncbi.nlm.nih.gov\/34669152\/.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"7717_CR92","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12985-023-02152-6","volume":"20","author":"R Rasizadeh","year":"2023","unstructured":"Rasizadeh R, Aghbash PS, Nahand JS, Entezari-Maleki T, Baghi HB. SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs. Virol J. 2023;20(1):179. https:\/\/doi.org\/10.1186\/s12985-023-02152-6. https:\/\/pubmed.ncbi.nlm.nih.gov\/37559103\/. Published 2023 Aug 9.","journal-title":"Virol J"},{"key":"7717_CR93","doi-asserted-by":"publisher","unstructured":"Alwafi HA, Ali SS, Kotha SB, et al. Elevated salivary inflammatory biomarkers are associated with SARS-CoV-2 infection severity. Can J Infect Dis Med Microbiol. 2022;1543918. Published 2022 None. doi: https:\/\/doi.org\/10.1155\/2022\/1543918. https:\/\/pubmed.ncbi.nlm.nih.gov\/35967091\/.","DOI":"10.1155\/2022\/1543918"},{"issue":"1","key":"7717_CR94","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2478\/rjim-2021-0037","volume":"60","author":"E Oikonomou","year":"2022","unstructured":"Oikonomou E, Paraskevas T, Velissaris D. Cardiac biomarkers alterations in patients with SARS-CoV-2 infection. Rom J Intern Med. 2022;60(1):6\u201313. https:\/\/doi.org\/10.2478\/rjim-2021-0037. https:\/\/pubmed.ncbi.nlm.nih.gov\/34610232\/. Published 2022 Mar 1.","journal-title":"Rom J Intern Med"},{"issue":"9","key":"7717_CR95","doi-asserted-by":"publisher","first-page":"e019756","DOI":"10.1161\/JAHA.120.019756","volume":"10","author":"PL Myhre","year":"2021","unstructured":"Myhre PL, Prebensen C, Jonassen CM, Berdal JE, Omland T. SARS-CoV-2 viremia is associated with inflammatory, but not cardiovascular biomarkers, in patients Hospitalized for COVID-19. J Am Heart Assoc. 2021;10(9):e019756. https:\/\/doi.org\/10.1161\/JAHA.120.019756. https:\/\/pubmed.ncbi.nlm.nih.gov\/33596668\/.","journal-title":"J Am Heart Assoc"},{"key":"7717_CR96","doi-asserted-by":"publisher","unstructured":"Georgakopoulou VE, Makrodimitri S, Triantafyllou M, et al. Immature granulocytes: innovative biomarker for SARS\u2011CoV\u20112 infection. Mol Med Rep. 2022;26(1). https:\/\/doi.org\/10.3892\/mmr.2022.12733. https:\/\/pubmed.ncbi.nlm.nih.gov\/35551416\/.","DOI":"10.3892\/mmr.2022.12733"},{"key":"7717_CR97","doi-asserted-by":"publisher","unstructured":"Zhang Z. Genomic biomarker heterogeneities between SARS-CoV-2 and COVID-19. Vaccines (Basel). 2022;10(10). https:\/\/doi.org\/10.3390\/vaccines10101657. https:\/\/pubmed.ncbi.nlm.nih.gov\/36298522\/. Published 2022 Oct 2.","DOI":"10.3390\/vaccines10101657"},{"key":"7717_CR98","doi-asserted-by":"publisher","unstructured":"Reyes-Ruiz JM, R\u00edos-R\u00edos M, Mart\u00ednez-Mier G. The assessment of the fibrinogen-to-platelet ratio for predicting mortality of COVID-19 in non-diabetic subjects. Int J Environ Health Res. 1\u201310. https:\/\/doi.org\/10.1080\/09603123.2025.2557428. https:\/\/pubmed.ncbi.nlm.nih.gov\/40916581\/. Published online Sep 8, 2025.","DOI":"10.1080\/09603123.2025.2557428"},{"key":"7717_CR99","doi-asserted-by":"publisher","unstructured":"Mariappan V, Ranganadin P, Shanmugam L, Rao SR, Balakrishna Pillai A. Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2. Biochimie. 201:139\u201347. https:\/\/doi.org\/10.1016\/j.biochi.2022.06.005. https:\/\/pubmed.ncbi.nlm.nih.gov\/35724946\/.","DOI":"10.1016\/j.biochi.2022.06.005"},{"key":"7717_CR100","doi-asserted-by":"publisher","unstructured":"Drummer HE, Van H, Klock E, et al. Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection. medRxiv. Published. 2021, Jul, 1. https:\/\/doi.org\/10.1101\/2021.06.28.21259671. https:\/\/pubmed.ncbi.nlm.nih.gov\/34230936\/.","DOI":"10.1101\/2021.06.28.21259671"},{"key":"7717_CR101","doi-asserted-by":"publisher","unstructured":"Ros-Lucas JA, Pascual-Figal DA, Noguera-Velasco JA, et al. CA 15\u20133 prognostic biomarker in SARS-CoV-2 pneumonia. Sci Rep. 2022;12(1):6738. https:\/\/doi.org\/10.1038\/s41598-022-10726-7. https:\/\/pubmed.ncbi.nlm.nih.gov\/35469047\/. Published 2022 Apr 25.","DOI":"10.1038\/s41598-022-10726-7"},{"key":"7717_CR102","doi-asserted-by":"publisher","unstructured":"Zhao Y, Xing H. Influence of fasting plasma glucose level on admission of COVID-19 patients: a retrospective study. J Diabetes Res. 2022;7424748. Published 2022 None. doi: https:\/\/doi.org\/10.1155\/2022\/7424748. https:\/\/pubmed.ncbi.nlm.nih.gov\/35005030\/.","DOI":"10.1155\/2022\/7424748"},{"issue":"1","key":"7717_CR103","doi-asserted-by":"publisher","first-page":"e12690","DOI":"10.7759\/cureus.12690","volume":"13","author":"YB Omotosho","year":"2021","unstructured":"Omotosho YB, Ying GW, Stolar M, Mallari AJP. COVID-19-Induced diabetic Ketoacidosis in an adult with latent autoimmune diabetes. Cureus. 2021, Jan, 13;13(1):e12690. Published 2021 https:\/\/doi.org\/10.7759\/cureus.12690. https:\/\/pubmed.ncbi.nlm.nih.gov\/33604221\/.","journal-title":"Cureus"},{"issue":"7","key":"7717_CR104","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/2666145415666221004111511","volume":"23","author":"G Akku\u015f","year":"2023","unstructured":"Akku\u015f G. Newly-onset autoimmune diabetes mellitus Triggered by COVID 19 infection: a case-based review. Endocr Metab Immune Disord Drug Targets. 2023;23(7):887\u201393. https:\/\/doi.org\/10.2174\/2666145415666221004111511. https:\/\/pubmed.ncbi.nlm.nih.gov\/36200218\/.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"11","key":"7717_CR105","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2174\/1871530323666230418092121","volume":"23","author":"I Ta\u015fkald\u0131ran","year":"2023","unstructured":"Ta\u015fkald\u0131ran I, Nar A. A case of new-onset autoimmune type-1 diabetes mellitus following COVID-19 infection. Endocr Metab Immune Disord Drug Targets. 2023;23(11):1455\u201357. https:\/\/doi.org\/10.2174\/1871530323666230418092121. https:\/\/pubmed.ncbi.nlm.nih.gov\/37076470\/.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"7717_CR106","doi-asserted-by":"publisher","first-page":"e33762","DOI":"10.7759\/cureus.33762","volume":"15","author":"K Bally","year":"2023","unstructured":"Bally K, Ji B, Soni L. COVID-19 vaccine-induced latent autoimmune diabetes in adults. Cureus. 2023;15(1):e33762. https:\/\/doi.org\/10.7759\/cureus.33762. https:\/\/pubmed.ncbi.nlm.nih.gov\/36793809\/. Published 2023 Jan.","journal-title":"Cureus"},{"issue":"10","key":"7717_CR107","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41574-024-01004-9","volume":"20","author":"C Debuysschere","year":"2024","unstructured":"Debuysschere C, Nekoua MP, Alidjinou EK, Hober D. The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus. Nat Rev Endocrinol. 2024;20(10):588\u201399. https:\/\/doi.org\/10.1038\/s41574-024-01004-9. https:\/\/pubmed.ncbi.nlm.nih.gov\/38890459\/.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"7717_CR108","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/imcb.12615","volume":"101","author":"R Anindya","year":"2023","unstructured":"Anindya R, Rutter GA, Meur G. New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection. Immunol Cell Biol. 2023;101(3):191\u2013203. https:\/\/doi.org\/10.1111\/imcb.12615. https:\/\/pubmed.ncbi.nlm.nih.gov\/36529987\/.","journal-title":"Immunol Cell Biol"},{"issue":"9","key":"7717_CR109","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/MEG.0000000000001804","volume":"32","author":"M Yuksel","year":"2020","unstructured":"Yuksel M, Akturk H, Arikan C. Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection. Eur J Gastroenterol Hepatol. 2020;32(9):1251\u201355. https:\/\/doi.org\/10.1097\/MEG.0000000000001804. https:\/\/pubmed.ncbi.nlm.nih.gov\/32541245\/.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"7717_CR110","doi-asserted-by":"publisher","unstructured":"Anderberg J, Carlsson P, Lundgren M, Elding Larsson H, Carlsson A. Increased incidence of type 1 diabetes and Co-existing thyroid autoimmunity during the COVID-19 pandemic in Sweden. Acta Paediatr. https:\/\/doi.org\/10.1111\/apa.70388. https:\/\/pubmed.ncbi.nlm.nih.gov\/41324147\/. Published online Dec 1, 2025.","DOI":"10.1111\/apa.70388"},{"issue":"6","key":"7717_CR111","doi-asserted-by":"publisher","first-page":"e0324513","DOI":"10.1371\/journal.pone.0324513","volume":"20","author":"S Wuller","year":"2025","unstructured":"Wuller S, Singer NG, Lewis C, et al. Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: a RECOVER initiative study in nationwide U.S. cohorts. PLoS One. 2025;20(6):e0324513. Published 2025 None. doi: https:\/\/doi.org\/10.1371\/journal.pone.0324513. https:\/\/pubmed.ncbi.nlm.nih.gov\/40465573\/.","journal-title":"PLoS One"},{"issue":"1","key":"7717_CR112","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1297\/cpe.2021-0050","volume":"31","author":"A Ata","year":"2022","unstructured":"Ata A, Jalilova A, K\u0131rkg\u00f6z T, et al. Does COVID-19 predispose patients to type 1 diabetes mellitus? Clin Pediatr Endocrinol. 2022;31(1):33\u201337. https:\/\/doi.org\/10.1297\/cpe.2021-0050. https:\/\/pubmed.ncbi.nlm.nih.gov\/35002066\/.","journal-title":"Clin Pediatr Endocrinol"},{"issue":"1","key":"7717_CR113","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12902-023-01424-0","volume":"23","author":"AS Alsudais","year":"2023","unstructured":"Alsudais AS, Alkanani RS, Fathi AB, et al. Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: a systematic review of case reports. BMC Endocr Disord. 2023;23(1):164. https:\/\/doi.org\/10.1186\/s12902-023-01424-0. https:\/\/pubmed.ncbi.nlm.nih.gov\/37542216\/. Published 2023 Aug 4.","journal-title":"BMC Endocr Disord"},{"issue":"8","key":"7717_CR114","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2169\/internalmedicine.9004-21","volume":"61","author":"M Yano","year":"2022","unstructured":"Yano M, Morioka T, Natsuki Y, et al. New-onset type 1 diabetes after COVID-19 mRNA vaccination. Intern Med. 2022;61(8):1197\u2013200. https:\/\/doi.org\/10.2169\/internalmedicine.9004-21. https:\/\/pubmed.ncbi.nlm.nih.gov\/35135929\/.","journal-title":"Intern Med"},{"issue":"3","key":"7717_CR115","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s13340-024-00695-9","volume":"15","author":"S Mochizuki","year":"2024","unstructured":"Mochizuki S, Miura J, Ucida K, et al. Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases and review of literature. Diabetol Int. 2024;15(3):577\u201382. https:\/\/doi.org\/10.1007\/s13340-024-00695-9. https:\/\/pubmed.ncbi.nlm.nih.gov\/39101197\/. Published 2024 Jul.","journal-title":"Diabetol Int"},{"key":"7717_CR116","doi-asserted-by":"publisher","unstructured":"Hayden MR. An immediate and long-term complication of COVID-19 May Be type 2 diabetes mellitus: the central role of \u03b2-cell dysfunction, apoptosis and exploration of possible mechanisms. In: Cells. Vol. 9(11). Published; 2020. 2020 Nov 13. doi: https:\/\/doi.org\/10.3390\/cells9112475. https:\/\/pubmed.ncbi.nlm.nih.gov\/33202960\/.","DOI":"10.3390\/cells9112475"},{"issue":"1","key":"7717_CR117","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1186\/s12967-024-05872-7","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li Q, Duan H, Tan L, Cao Y, Chen J. Machine learning based predictive modeling and risk factors for prolonged SARS-CoV-2 shedding. J Transl Med. 2024;22(1):1054. https:\/\/doi.org\/10.1186\/s12967-024-05872-7. https:\/\/pubmed.ncbi.nlm.nih.gov\/39578848\/. Published 2024 Nov 22.","journal-title":"J Transl Med"},{"issue":"1","key":"7717_CR118","doi-asserted-by":"publisher","first-page":"25696","DOI":"10.1038\/s41598-025-09229-y","volume":"15","author":"D Ferrer-Pargada","year":"2025","unstructured":"Ferrer-Pargada D, Amado CA, Abascal-Bolado B, et al. FeNO as a biomarker of interstitial and fibrotic pulmonary sequelae in patients admitted for severe SARS-CoV-2 pneumonia. Sci Rep. 2025;15(1):25696. https:\/\/doi.org\/10.1038\/s41598-025-09229-y. https:\/\/pubmed.ncbi.nlm.nih.gov\/40670513\/. Published 2025 Jul 16.","journal-title":"Sci Rep"},{"issue":"21","key":"7717_CR119","doi-asserted-by":"publisher","first-page":"e70388","DOI":"10.1002\/cam4.70388","volume":"13","author":"Y Sun","year":"2024","unstructured":"Sun Y, Hu C, Hu S, et al. Predicting pancreatic Cancer in new-onset diabetes cohort using a novel model with integrated clinical and genetic indicators: a large-scale prospective cohort study. Cancer Med. 2024;13(21):e70388. https:\/\/doi.org\/10.1002\/cam4.70388. https:\/\/pubmed.ncbi.nlm.nih.gov\/39526476\/.","journal-title":"Cancer Med"},{"issue":"10","key":"7717_CR120","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00125-024-06231-3","volume":"67","author":"AT Lundgaard","year":"2024","unstructured":"Lundgaard AT, Westergaard D, R\u00f6der T, et al. Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control study. Diabetologia. 2024;67(10):2289\u2013303. https:\/\/doi.org\/10.1007\/s00125-024-06231-3. https:\/\/pubmed.ncbi.nlm.nih.gov\/39078488\/.","journal-title":"Diabetologia"},{"key":"7717_CR121","doi-asserted-by":"publisher","unstructured":"Osmanodja B, Stegbauer J, Kantauskaite M, et al. Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients. Front Immunol. 13:997343. Published 2022 None. doi: https:\/\/doi.org\/10.3389\/fimmu.2022.997343. https:\/\/pubmed.ncbi.nlm.nih.gov\/36268021\/.","DOI":"10.3389\/fimmu.2022.997343"},{"issue":"1","key":"7717_CR122","doi-asserted-by":"publisher","first-page":"13879","DOI":"10.1038\/s41598-022-17953-y","volume":"12","author":"AG Zucco","year":"2022","unstructured":"Zucco AG, Agius R, Svanberg R, et al. Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning. Sci Rep. 2022;12(1):13879. https:\/\/doi.org\/10.1038\/s41598-022-17953-y. https:\/\/pubmed.ncbi.nlm.nih.gov\/35974050\/. Published 2022 Aug 16.","journal-title":"Sci Rep"},{"issue":"12","key":"7717_CR123","doi-asserted-by":"publisher","first-page":"e0316207","DOI":"10.1371\/journal.pone.0316207","volume":"19","author":"SL Valderrama-Beltr\u00e1n","year":"2024","unstructured":"Valderrama-Beltr\u00e1n SL, Cuervo-Rojas J, Rond\u00f3n M, et al. Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings. PLoS One. 2024;19(12):e0316207. Published 2024 None. doi: https:\/\/doi.org\/10.1371\/journal.pone.0316207. https:\/\/pubmed.ncbi.nlm.nih.gov\/39724211\/.","journal-title":"PLoS One"},{"issue":"4","key":"7717_CR124","doi-asserted-by":"publisher","first-page":"e28739","DOI":"10.1002\/jmv.28739","volume":"95","author":"J Camacho","year":"2023","unstructured":"Camacho J, Albert E, \u00c1lvarez-Rodr\u00edguez B, et al. A machine learning model for predicting serum neutralizing activity against Omicron SARS-CoV-2 BA.2 and BA.4\/5 sublineages in the general population. J Med Virol. 2023;95(4):e28739. https:\/\/doi.org\/10.1002\/jmv.28739. https:\/\/pubmed.ncbi.nlm.nih.gov\/37185857\/.","journal-title":"J Med Virol"},{"issue":"4","key":"7717_CR125","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s13167-025-00422-7","volume":"16","author":"J Zhu","year":"2025","unstructured":"Zhu J, Wang Y, Duan S, et al. Multivariable data-driven framework of predictive, preventive, and personalized medicine for long-term atrial fibrillation risk in patients with new-onset obstructive sleep apnea. Epma J. 2025;16(4):761\u201372. https:\/\/doi.org\/10.1007\/s13167-025-00422-7. https:\/\/pubmed.ncbi.nlm.nih.gov\/41311997\/. Published 2025 Dec.","journal-title":"Epma J"},{"issue":"1","key":"7717_CR126","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41746-021-00482-9","volume":"4","author":"MD Rinderknecht","year":"2021","unstructured":"Rinderknecht MD, Klopfenstein Y. Predicting critical state after COVID-19 diagnosis: model development using a large US electronic health record dataset. NPJ Digit Med. 2021;4(1):113. https:\/\/doi.org\/10.1038\/s41746-021-00482-9. https:\/\/pubmed.ncbi.nlm.nih.gov\/34285316\/. Published 2021 Jul 20.","journal-title":"NPJ Digit Med"},{"issue":"7","key":"7717_CR127","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s11739-022-03014-9","volume":"17","author":"M El Halabi","year":"2022","unstructured":"El Halabi M, Feghali J, Bahk J, et al. A novel evidence-based predictor tool for hospitalization and length of stay: insights from COVID-19 patients in New York city. Intern Emerg Med. 2022;17(7):1879\u201389. https:\/\/doi.org\/10.1007\/s11739-022-03014-9. https:\/\/pubmed.ncbi.nlm.nih.gov\/35773370\/.","journal-title":"Intern Emerg Med"},{"issue":"1","key":"7717_CR128","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/ID9.0000000000000001","volume":"1","author":"HL Chen","year":"2021","unstructured":"Chen HL, Yan WM, Chen G, et al. CAPRL scoring System for prediction of 30-day mortality in 949 patients with coronavirus disease 2019 in Wuhan, China: a retrospective, Observational study. Infect Dis Immun. 2021;1(1):28\u201335. https:\/\/doi.org\/10.1097\/ID9.0000000000000001. https:\/\/pubmed.ncbi.nlm.nih.gov\/38630115\/. Published 2021 Apr.","journal-title":"Infect Dis Immun"},{"key":"7717_CR129","doi-asserted-by":"publisher","unstructured":"Xiao YF, He JL, Xu Y, et al. Major characteristics of severity and mortality in diabetic patients with COVID-19 and establishment of severity risk Score. Front Med (Lausanne). 8:655604. Published 2021 None. doi: https:\/\/doi.org\/10.3389\/fmed.2021.655604. https:\/\/pubmed.ncbi.nlm.nih.gov\/34164413\/.","DOI":"10.3389\/fmed.2021.655604"},{"key":"7717_CR130","doi-asserted-by":"publisher","unstructured":"Hsieh YC, Chen S, Tsao SY, Hu JR, Hsu WT, Lee CC. Using machine learning methods to investigate the impact of comorbidities and clinical indicators on the mortality rate of COVID-19. Front Med Technol. 7:1621158. Published 2025 None. doi: https:\/\/doi.org\/10.3389\/fmedt.2025.1621158. https:\/\/pubmed.ncbi.nlm.nih.gov\/41059076\/.","DOI":"10.3389\/fmedt.2025.1621158"},{"key":"7717_CR131","doi-asserted-by":"publisher","unstructured":"Shin J, Toyoda S, Nishitani S, et al. SARS-CoV-2 infection impairs the insulin\/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1. Metabolism. 133:155236. https:\/\/doi.org\/10.1016\/j.metabol.2022.155236. https:\/\/pubmed.ncbi.nlm.nih.gov\/35688210\/.","DOI":"10.1016\/j.metabol.2022.155236"},{"issue":"7","key":"7717_CR132","doi-asserted-by":"publisher","first-page":"e1004274","DOI":"10.1371\/journal.pmed.1004274","volume":"20","author":"X Xiong","year":"2023","unstructured":"Xiong X, Lui DTW, Chung MSH, et al. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: a population-based cohort study. PLoS Med. 2023;20(7):e1004274. https:\/\/doi.org\/10.1371\/journal.pmed.1004274. https:\/\/pubmed.ncbi.nlm.nih.gov\/37486927\/. Published 2023 Jul.","journal-title":"PLoS Med"},{"issue":"10","key":"7717_CR133","doi-asserted-by":"publisher","first-page":"e0333052","DOI":"10.1371\/journal.pone.0333052","volume":"20","author":"AR Titus","year":"2025","unstructured":"Titus AR, Kanchi R, Adhikari S, et al. Time-varying associations between diabetes and mortality following COVID-19: evidence from a U.S. Veteran population. PLoS One. 2025;20(10):e0333052. Published 2025 None. doi: https:\/\/doi.org\/10.1371\/journal.pone.0333052. https:\/\/pubmed.ncbi.nlm.nih.gov\/41060911\/.","journal-title":"PLoS One"},{"key":"7717_CR134","doi-asserted-by":"publisher","unstructured":"Prado-Galbarro FJ, Sanchez-Piedra C, Gami\u00f1o-Arroyo AE, Cruz-Cruz C. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients. Public Health. 189:66\u201372. https:\/\/doi.org\/10.1016\/j.puhe.2020.09.014. https:\/\/pubmed.ncbi.nlm.nih.gov\/33166857\/.","DOI":"10.1016\/j.puhe.2020.09.014"},{"key":"7717_CR135","doi-asserted-by":"publisher","unstructured":"Young-Wolff KC, Slama N, Sakoda LC, Prochaska JJ, Fogelberg R, Alexeeff SE. Current tobacco smoking and risk of SARS-CoV-2 infection and hospitalization: evaluating the role of socio-demographic factors and comorbidities. Prev Med. 172:107523. https:\/\/doi.org\/10.1016\/j.ypmed.2023.107523. https:\/\/pubmed.ncbi.nlm.nih.gov\/37116761\/.","DOI":"10.1016\/j.ypmed.2023.107523"},{"key":"7717_CR136","doi-asserted-by":"publisher","unstructured":"Fu Y, Hu L, Ren HW, et al. Prognostic factors for COVID-19 Hospitalized patients with preexisting type 2 diabetes. Int J Endocrinol. 2022;9322332. Published 2022 None. doi: https:\/\/doi.org\/10.1155\/2022\/9322332. https:\/\/pubmed.ncbi.nlm.nih.gov\/35047039\/.","DOI":"10.1155\/2022\/9322332"},{"key":"7717_CR137","doi-asserted-by":"publisher","unstructured":"Sansone NMS, Boschiero MN, Ortega MM, et al. Severe acute respiratory syndrome by SARS-CoV-2 infection or other etiologic agents among Brazilian indigenous population: an Observational study from the first year of coronavirus disease (COVID)-19 pandemic. Lancet Reg Health Am. 8:100177. https:\/\/doi.org\/10.1016\/j.lana.2021.100177. https:\/\/pubmed.ncbi.nlm.nih.gov\/35018359\/.","DOI":"10.1016\/j.lana.2021.100177"},{"issue":"1","key":"7717_CR138","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12902-025-02056-2","volume":"25","author":"F Mohamed","year":"2025","unstructured":"Mohamed F, Gunter S, Yirdaw BE, Raal FJ, Millen AME, Kalla IS. Predictive diagnostic models for newly diagnosed diabetes mellitus in moderate to severe COVID-19: the role of TyG index, BMI, and inflammatory markers. BMC Endocr Disord. 2025;25(1):245. https:\/\/doi.org\/10.1186\/s12902-025-02056-2. https:\/\/pubmed.ncbi.nlm.nih.gov\/41163007\/. Published 2025 Oct 30.","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"7717_CR139","doi-asserted-by":"publisher","first-page":"e2439444","DOI":"10.1001\/jamanetworkopen.2024.39444","volume":"7","author":"MG Miller","year":"2024","unstructured":"Miller MG, Terebuh P, Kaelber DC, Xu R, Davis PB. SARS-CoV-2 infection and new-onset type 2 diabetes among pediatric patients & comma; 2020 to 2022. JAMA Netw Open. 2024;7(10):e2439444. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.39444. https:\/\/pubmed.ncbi.nlm.nih.gov\/39401034\/. Published 2024 Oct 1.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"7717_CR140","doi-asserted-by":"publisher","first-page":"e70084","DOI":"10.1111\/dme.70084","volume":"42","author":"JL Ward","year":"2025","unstructured":"Ward JL, Cruz J, Harwood R, et al. SARS-CoV-2 infection and new-onset type 1 diabetes in the post-acute period among children and young people in England. Diabet Med. 2025;42(9):e70084. https:\/\/doi.org\/10.1111\/dme.70084. https:\/\/pubmed.ncbi.nlm.nih.gov\/40525655\/.","journal-title":"Diabet Med"},{"key":"7717_CR141","doi-asserted-by":"publisher","unstructured":"F\u0103g\u0103r\u0103\u0219an I, Rusu A, Cristea M, et al. Predictors of new-onset diabetes in Hospitalized patients with SARS-CoV-2 infection. Int J Environ Res Public Health. 2022;19(20). https:\/\/doi.org\/10.3390\/ijerph192013230. https:\/\/pubmed.ncbi.nlm.nih.gov\/36293811\/. Published 2022 Oct 14.","DOI":"10.3390\/ijerph192013230"},{"issue":"1","key":"7717_CR142","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s44194-022-00006-x","volume":"1","author":"JK Yang","year":"2022","unstructured":"Yang JK, Zhao MM, Jin JM, et al. New-onset COVID-19-related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection. Curr Med (Cham). 2022;1(1):6. https:\/\/doi.org\/10.1007\/s44194-022-00006-x. https:\/\/pubmed.ncbi.nlm.nih.gov\/35673632\/.","journal-title":"Curr Med (Cham)"},{"key":"7717_CR143","doi-asserted-by":"publisher","unstructured":"Reddy NV, Yeh HC, Tronieri JS, et al. Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? medRxiv. https:\/\/doi.org\/10.1101\/2022.12.02.22283029. https:\/\/pubmed.ncbi.nlm.nih.gov\/36482974\/. Published 2022 Dec 4.","DOI":"10.1101\/2022.12.02.22283029"},{"issue":"5","key":"7717_CR144","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2337\/db22-0264","volume":"72","author":"A Sharma","year":"2023","unstructured":"Sharma A, Misra-Hebert AD, Mariam A, et al. Impacts of COVID-19 on glycemia and risk of diabetic Ketoacidosis. Diabetes. 2023;72(5):627\u201337. https:\/\/doi.org\/10.2337\/db22-0264. https:\/\/pubmed.ncbi.nlm.nih.gov\/36107493\/.","journal-title":"Diabetes"},{"key":"7717_CR145","doi-asserted-by":"publisher","unstructured":"Qadir MMF, Bhondeley M, Beatty W, et al. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes. JCI Insight. 2021;6(16). Published https:\/\/doi.org\/10.1172\/jci.insight.151551. https:\/\/pubmed.ncbi.nlm.nih.gov\/34241597\/. 2021 Aug 23.","DOI":"10.1172\/jci.insight.151551"},{"key":"7717_CR146","doi-asserted-by":"publisher","unstructured":"Jedrzejak AP, Urbaniak EK, Wasko JA, Ziojla N, Borowiak M. Diabetes and SARS-CoV-2-Is there a mutual connection? Front Cell Dev Biol. 10:913305. Published 2022 None. doi: https:\/\/doi.org\/10.3389\/fcell.2022.913305. https:\/\/pubmed.ncbi.nlm.nih.gov\/35769263\/.","DOI":"10.3389\/fcell.2022.913305"},{"issue":"6464","key":"7717_CR147","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.aax2342.https:\/\/pubmed.ncbi.nlm.nih.gov\/31649194\/","volume":"366","author":"Z Obermeyer","year":"2019","unstructured":"Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447\u201353. https:\/\/doi.org\/10.1126\/science.aax2342.https:\/\/pubmed.ncbi.nlm.nih.gov\/31649194\/.","journal-title":"Science"},{"issue":"2","key":"7717_CR148","doi-asserted-by":"publisher","first-page":"e2255965","DOI":"10.1001\/jamanetworkopen.2022.55965","volume":"6","author":"AC Kwan","year":"2023","unstructured":"Kwan AC, Ebinger JE, Botting P, Navarrette J, Claggett B, Cheng S. Association of COVID-19 vaccination with risk for Incident diabetes after COVID-19 infection. JAMA Netw Open. 2023;6(2):e2255965. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55965. https:\/\/pubmed.ncbi.nlm.nih.gov\/36787145\/. Published 2023 Feb 1.","journal-title":"JAMA Netw Open"},{"key":"7717_CR149","doi-asserted-by":"publisher","unstructured":"Bellido V, P\u00e9rez A. COVID-19 and Diabetes. J Clin Med. 2021;10(22). https:\/\/doi.org\/10.3390\/jcm10225341. https:\/\/pubmed.ncbi.nlm.nih.gov\/34830623\/. Published 2021 Nov 16.","DOI":"10.3390\/jcm10225341"},{"issue":"4","key":"7717_CR150","doi-asserted-by":"publisher","first-page":"e238866","DOI":"10.1001\/jamanetworkopen.2023.8866","volume":"6","author":"Z Naveed","year":"2023","unstructured":"Naveed Z, Vel\u00e1squez Garc\u00eda HA, Wong S, et al. Association of COVID-19 infection with Incident diabetes. JAMA Netw Open. 2023;6(4):e238866. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.8866. https:\/\/pubmed.ncbi.nlm.nih.gov\/37071420\/. Published 2023 Apr 3.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"7717_CR151","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11606-024-09035-8","volume":"40","author":"JS Varghese","year":"2025","unstructured":"Varghese JS, Ali MK, Guo Y, Donahoo WT, Chakkalakal RJ. Risk of new-onset diabetes before and during the COVID-19 pandemic: a real-World cohort study. J Gen Intern Med. 2025;40(6):1315\u201324. https:\/\/doi.org\/10.1007\/s11606-024-09035-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/39302562\/.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"7717_CR152","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.2337\/dc24-1003","volume":"47","author":"R Wong","year":"2024","unstructured":"Wong R, Hall MA, Wiggen T, et al. Effect of SARS-CoV-2 infection on Incident diabetes by viral variant: findings from the national COVID cohort collaborative (N3C). Diabetes Care. 2024;47(10):1846\u201354. https:\/\/doi.org\/10.2337\/dc24-1003. https:\/\/pubmed.ncbi.nlm.nih.gov\/39207804\/.","journal-title":"Diabetes Care"},{"key":"7717_CR153","doi-asserted-by":"publisher","unstructured":"Xu AY, Wang SH, Duong TQ. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study. BMJ Open Diabetes Res Care. 2023;11(3). https:\/\/doi.org\/10.1136\/bmjdrc-2022-003257. https:\/\/pubmed.ncbi.nlm.nih.gov\/37295808\/.","DOI":"10.1136\/bmjdrc-2022-003257"},{"issue":"10","key":"7717_CR154","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00592-023-02103-1","volume":"60","author":"C Tiberti","year":"2023","unstructured":"Tiberti C, Nenna R, Tromba V, et al. No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects. Acta Diabetol. 2023;60(10):1301\u201307. https:\/\/doi.org\/10.1007\/s00592-023-02103-1. https:\/\/pubmed.ncbi.nlm.nih.gov\/37171699\/.","journal-title":"Acta Diabetol"},{"issue":"12","key":"7717_CR155","doi-asserted-by":"publisher","first-page":"e29300","DOI":"10.1002\/jmv.29300","volume":"95","author":"J Li","year":"2023","unstructured":"Li J, Liu Y, Wei X, et al. Antibody responses to SARS-CoV-2 Omicron infection in patients with hematological malignancies: a multicenter, prospective cohort study. J Med Virol. 2023;95(12):e29300. https:\/\/doi.org\/10.1002\/jmv.29300. https:\/\/pubmed.ncbi.nlm.nih.gov\/38063070\/.","journal-title":"J Med Virol"},{"issue":"1","key":"7717_CR156","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13054-021-03720-4","volume":"25","author":"H Magunia","year":"2021","unstructured":"Magunia H, Lederer S, Verbuecheln R, et al. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort. Crit Care. 2021;25(1):295. https:\/\/doi.org\/10.1186\/s13054-021-03720-4. https:\/\/pubmed.ncbi.nlm.nih.gov\/34404458\/. Published 2021 Aug 17.","journal-title":"Crit Care"},{"issue":"10","key":"7717_CR157","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.6002\/ect.2021.0284","volume":"19","author":"VB Kute","year":"2021","unstructured":"Kute VB, Hegde U, Das P, et al. A multicenter cohort study of Indian centers on reoccurring SARS-CoV-2 infections in kidney transplant recipients. Exp Clin Transpl. 2021;19(10):1023\u201331. https:\/\/doi.org\/10.6002\/ect.2021.0284. https:\/\/pubmed.ncbi.nlm.nih.gov\/34498549\/.","journal-title":"Exp Clin Transpl"},{"issue":"9","key":"7717_CR158","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cmi.2022.04.001","volume":"28","author":"M Massalha","year":"2022","unstructured":"Massalha M, Yefet E, Rozenberg O, et al. Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2: a prospective multicenter cohort study. Clin Microbiol Infect. 2022;28(9):1258\u201362. https:\/\/doi.org\/10.1016\/j.cmi.2022.04.001. https:\/\/pubmed.ncbi.nlm.nih.gov\/35427778\/.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"7717_CR159","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270\u201384. https:\/\/doi.org\/10.1038\/s41579-022-00713-0. https:\/\/pubmed.ncbi.nlm.nih.gov\/35354968\/.","journal-title":"Nat Rev Microbiol"},{"key":"7717_CR160","doi-asserted-by":"publisher","unstructured":"Zhang X, Deng X, Zhang L, et al. Single-cell RNA sequencing analysis of lung cells in COVID-19 patients with diabetes, hypertension, and comorbid diabetes-hypertension. Front Endocrinol (Lausanne). 14:1258646. Published 2023 None. doi: https:\/\/doi.org\/10.3389\/fendo.2023.1258646. https:\/\/pubmed.ncbi.nlm.nih.gov\/38144556\/.","DOI":"10.3389\/fendo.2023.1258646"},{"key":"7717_CR161","doi-asserted-by":"publisher","unstructured":"Ilic I, Ilic M. Diabetes mellitus after SARS-CoV-2 infection: an epidemiological review. Life (Basel). 2023;13(6). Published https:\/\/doi.org\/10.3390\/life13061233. https:\/\/pubmed.ncbi.nlm.nih.gov\/37374016\/. 2023 May 23.","DOI":"10.3390\/life13061233"},{"key":"7717_CR162","doi-asserted-by":"publisher","unstructured":"Setz C, Gro\u00dfe M, Auth J, et al. Synergistic antiviral activity of Pamapimod and Pioglitazone against SARS-CoV-2 and its variants of concern. Int J Mol Sci. 2022;23(12). https:\/\/doi.org\/10.3390\/ijms23126830. https:\/\/pubmed.ncbi.nlm.nih.gov\/35743273\/. Published 2022 Jun 20.","DOI":"10.3390\/ijms23126830"},{"key":"7717_CR163","doi-asserted-by":"publisher","unstructured":"Li XT, Zhang MW, Zhang ZZ, et al. Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19. Int J Cardiol. 336:123\u201329. https:\/\/doi.org\/10.1016\/j.ijcard.2021.05.029. https:\/\/pubmed.ncbi.nlm.nih.gov\/34000358\/.","DOI":"10.1016\/j.ijcard.2021.05.029"},{"issue":"7982","key":"7717_CR164","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41586-023-06609-0","volume":"622","author":"Y Duan","year":"2023","unstructured":"Duan Y, Zhou H, Liu X, et al. Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir. Nature. 2023;622(7982):376\u201382. https:\/\/doi.org\/10.1038\/s41586-023-06609-0. https:\/\/pubmed.ncbi.nlm.nih.gov\/37696289\/.","journal-title":"Nature"},{"issue":"1","key":"7717_CR165","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s42003-023-05071-y","volume":"6","author":"M Lin","year":"2023","unstructured":"Lin M, Zeng X, Duan Y, et al. Molecular mechanism of ensitrelvir inhibiting SARS-CoV-2 main protease and its variants. Commun Biol. 2023;6(1):694. https:\/\/doi.org\/10.1038\/s42003-023-05071-y. https:\/\/pubmed.ncbi.nlm.nih.gov\/37407698\/. Published 2023 Jul 5.","journal-title":"Commun Biol"},{"issue":"1","key":"7717_CR166","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/s41467-022-32216-0","volume":"13","author":"C Zhu","year":"2022","unstructured":"Zhu C, Lee JY, Woo JZ, et al. An intranasal ASO therapeutic targeting SARS-CoV-2. Nat Commun. 2022;13(1):4503. https:\/\/doi.org\/10.1038\/s41467-022-32216-0. https:\/\/pubmed.ncbi.nlm.nih.gov\/35922434\/. Published 2022 Aug 3.","journal-title":"Nat Commun"},{"issue":"2","key":"7717_CR167","doi-asserted-by":"publisher","first-page":"e0281281","DOI":"10.1371\/journal.pone.0281281","volume":"18","author":"Y Qiao","year":"2023","unstructured":"Qiao Y, Wotring JW, Zhang CJ, et al. Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection. PLoS One. 2023;18(2):e0281281. Published 2023 None. doi: https:\/\/doi.org\/10.1371\/journal.pone.0281281. https:\/\/pubmed.ncbi.nlm.nih.gov\/36735698\/.","journal-title":"PLoS One"},{"issue":"2","key":"7717_CR168","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1021\/acsabm.2c00916","volume":"6","author":"A Ganguly","year":"2023","unstructured":"Ganguly A, Mandi M, Dutta A, Rajak P. In silico analysis reveals the inhibitory potential of madecassic acid against entry factors of SARS-CoV-2. ACS Appl Bio Mater. 2023;6(2):652\u201362. https:\/\/doi.org\/10.1021\/acsabm.2c00916. https:\/\/pubmed.ncbi.nlm.nih.gov\/36608326\/.","journal-title":"ACS Appl Bio Mater"},{"key":"7717_CR169","doi-asserted-by":"publisher","unstructured":"Kumar S, Paul P, Yadav P, et al. A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle. Comput Biol Med. 142:105231. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105231. https:\/\/pubmed.ncbi.nlm.nih.gov\/35032740\/.","DOI":"10.1016\/j.compbiomed.2022.105231"},{"issue":"3","key":"7717_CR170","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s44321-024-00188-x","volume":"17","author":"H Baazim","year":"2025","unstructured":"Baazim H, Koyuncu E, Tuncman G, et al. FABP4 as a therapeutic host target controlling SARS-CoV-2 infection. EMBO Mol Med. 2025;17(3):414\u201340. https:\/\/doi.org\/10.1038\/s44321-024-00188-x. https:\/\/pubmed.ncbi.nlm.nih.gov\/39843629\/.","journal-title":"EMBO Mol Med"},{"issue":"12","key":"7717_CR171","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.7150\/ijbs.72709","volume":"18","author":"TT Yuen","year":"2022","unstructured":"Yuen TT, Chan JF, Yan B, et al. Targeting ACLY efficiently inhibits SARS-CoV-2 replication. Int J Biol Sci. 2022;18(12):4714\u201330. Published 2022 None. doi: https:\/\/doi.org\/10.7150\/ijbs.72709. https:\/\/pubmed.ncbi.nlm.nih.gov\/35874959\/.","journal-title":"Int J Biol Sci"},{"key":"7717_CR172","doi-asserted-by":"publisher","unstructured":"Bergman M, Jagannathan R, Narayan KMV. Nexus of COVID-19 and diabetes pandemics: global public health lessons. Diabetes Res Clin Pract. 164:108215. https:\/\/doi.org\/10.1016\/j.diabres.2020.108215. https:\/\/pubmed.ncbi.nlm.nih.gov\/32416122\/.","DOI":"10.1016\/j.diabres.2020.108215"},{"issue":"1","key":"7717_CR173","doi-asserted-by":"publisher","first-page":"5","DOI":"10.46234\/ccdcw2023.002","volume":"5","author":"F Zhang","year":"2023","unstructured":"Zhang F, Zhu Y, He Z, et al. Uptake of heterologous or homologous COVID-19 booster dose and related adverse events among diabetic patients: a multicenter cross-sectional study - China, 2022. China CDC Wkly. 2023;5(1):5\u201310. https:\/\/doi.org\/10.46234\/ccdcw2023.002. https:\/\/pubmed.ncbi.nlm.nih.gov\/36777467\/.","journal-title":"China CDC Wkly"},{"issue":"5","key":"7717_CR174","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3803\/EnM.2024.2014","volume":"39","author":"HN Jang","year":"2024","unstructured":"Jang HN, Moon SJ, Jung JH, Han KD, Rhee EJ, Lee WY. Impact of diabetes on COVID-19 susceptibility: a nationwide propensity Score matching study. Endocrinol Metab (Seoul). 2024;39(5):813\u201318. https:\/\/doi.org\/10.3803\/EnM.2024.2014. https:\/\/pubmed.ncbi.nlm.nih.gov\/39192772\/.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"7717_CR175","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S2213-8587(22)00324-2","volume":"11","author":"Z Al-Aly","year":"2023","unstructured":"Al-Aly Z. Diabetes after SARS-CoV-2 infection. Lancet Diabetes Endocrinol. 2023;11(1):11\u201313. https:\/\/doi.org\/10.1016\/S2213-8587(22)00324-2. https:\/\/pubmed.ncbi.nlm.nih.gov\/36463908\/.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"7717_CR176","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1210\/clinem\/dgab792","volume":"107","author":"A Laurenzi","year":"2022","unstructured":"Laurenzi A, Caretto A, Molinari C, et al. No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection. J Clin Endocrinol Metab. 2022;107(3):e1009\u201319. https:\/\/doi.org\/10.1210\/clinem\/dgab792. https:\/\/pubmed.ncbi.nlm.nih.gov\/34718627\/.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7717_CR177","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4239\/wjd.v12.i3.198","volume":"12","author":"TA Chowdhury","year":"2021","unstructured":"Chowdhury TA. Diabetes and COVID-19: diseases of racial, social and glucose intolerance. World J Diabetes. 2021;12(3):198\u2013205. https:\/\/doi.org\/10.4239\/wjd.v12.i3.198. https:\/\/pubmed.ncbi.nlm.nih.gov\/33758642\/.","journal-title":"World J Diabetes"},{"issue":"5","key":"7717_CR178","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00112-020-01108-2","volume":"169","author":"K M\u00f6nkem\u00f6ller","year":"2021","unstructured":"M\u00f6nkem\u00f6ller K, Kamrath C, Hammersen J, et al. Is it possible to prevent diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes? Lessons from the COVID-19 pandemic. Monatsschr Kinderheilkd. 2021;169(5):451\u201360. https:\/\/doi.org\/10.1007\/s00112-020-01108-2. https:\/\/pubmed.ncbi.nlm.nih.gov\/33437098\/.","journal-title":"Monatsschr Kinderheilkd"},{"issue":"1","key":"7717_CR179","doi-asserted-by":"publisher","first-page":"e0262642","DOI":"10.1371\/journal.pone.0262642","volume":"17","author":"F Bojola","year":"2022","unstructured":"Bojola F, Taye W, Samuel H, Mulatu B, Kawza A, Mekuria A. Non-communicable diseases (NCDs) and vulnerability to COVID-19: the case of adult patients with hypertension or diabetes mellitus in Gamo, Gofa, and South Omo zones in southern Ethiopia. PLoS One. 2022;17(1):e0262642. Published 2022 None. doi: https:\/\/doi.org\/10.1371\/journal.pone.0262642. https:\/\/pubmed.ncbi.nlm.nih.gov\/35077488\/.","journal-title":"PLoS One"},{"issue":"7","key":"7717_CR180","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.dsx.2022.102537","volume":"16","author":"RA Pamungkas","year":"2022","unstructured":"Pamungkas RA, Usman AM, Chamroonsawasdi K, Abdurrasyid. A smartphone application of diabetes coaching intervention to prevent the onset of complications and to improve diabetes self-management: a randomized control trial. Diabetes Metab Syndr. 2022;16(7):102537. https:\/\/doi.org\/10.1016\/j.dsx.2022.102537. https:\/\/pubmed.ncbi.nlm.nih.gov\/35724489\/.","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"7717_CR181","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.dsx.2020.08.022","volume":"14","author":"DM Mukona","year":"2020","unstructured":"Mukona DM, Zvinavashe M. Self- management of diabetes mellitus during the covid-19 pandemic: recommendations for a resource limited setting. Diabetes Metab Syndr. 2020, Nov-Dec;14(6):1575\u201378. https:\/\/doi.org\/10.1016\/j.dsx.2020.08.022. https:\/\/pubmed.ncbi.nlm.nih.gov\/32858475\/.","journal-title":"Diabetes Metab Syndr"},{"key":"7717_CR182","doi-asserted-by":"publisher","unstructured":"Bao Y, Dong C, Liang Q, Zhang X, Gu Z, Cheng C. The difference of COVID-19 vaccination attitude, preventive measures and Knowledge of SARS-COV-2 between diabetic patients and healthy citizens in China. J Multidiscip Healthc. 16:493\u2013502. Published 2023 None. doi: https:\/\/doi.org\/10.2147\/JMDH.S394790. https:\/\/pubmed.ncbi.nlm.nih.gov\/36861134\/.","DOI":"10.2147\/JMDH.S394790"},{"issue":"4","key":"7717_CR183","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7326\/M20-6141","volume":"174","author":"M Alsan","year":"2021","unstructured":"Alsan M, Stanford FC, Banerjee A, et al. Comparison of Knowledge and Information-seeking behavior after general COVID-19 public health Messages and Messages tailored for black and latinx communities: a randomized controlled trial. Ann Intern Med. 2021;174(4):484\u201392. https:\/\/doi.org\/10.7326\/M20-6141. https:\/\/pubmed.ncbi.nlm.nih.gov\/33347320\/.","journal-title":"Ann Intern Med"},{"key":"7717_CR184","doi-asserted-by":"publisher","unstructured":"Budhwani H, Maragh-Bass AC, Tolley EE, et al. Tough talks COVID-19 digital health intervention for vaccine hesitancy among black young adults: protocol for a hybrid type 1 effectiveness implementation randomized controlled trial. JMIR Res Protoc. 12:e41240. https:\/\/doi.org\/10.2196\/41240. https:\/\/pubmed.ncbi.nlm.nih.gov\/36689557\/. Published 2023 Feb 13.","DOI":"10.2196\/41240"},{"key":"7717_CR185","doi-asserted-by":"publisher","unstructured":"Singer ME, Dorrance KA, Oxenreiter MM, Yan KR, Close KL. The type 2 diabetes \u2018modern preventable pandemic\u2019 and replicable lessons from the COVID-19 crisis. Prev Med Rep. 25:101636. https:\/\/doi.org\/10.1016\/j.pmedr.2021.101636. https:\/\/pubmed.ncbi.nlm.nih.gov\/34909369\/.","DOI":"10.1016\/j.pmedr.2021.101636"},{"issue":"8","key":"7717_CR186","doi-asserted-by":"publisher","first-page":"e3346","DOI":"10.1002\/dmrr.3346","volume":"36","author":"I Caruso","year":"2020","unstructured":"Caruso I, Giorgino F. The diabetic lung: an easy target for SARS-CoV-2? Diabetes Metab Res Rev. 2020;36(8):e3346. https:\/\/doi.org\/10.1002\/dmrr.3346. https:\/\/pubmed.ncbi.nlm.nih.gov\/32426928\/.","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07717-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07717-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07717-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:03:34Z","timestamp":1771333414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07717-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":186,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7717"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07717-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"266"}}